Stockreport

Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and ...

Hoth Therapeutics, Inc.  (HOTH) 
PDF Safety and tolerability findings included: No serious adverse events (0%) No dose-limiting toxicities observed. No treatment discontinuations due to adverse event [Read more]